{
    "code": "52028431",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52028431",
    "time": "2024-03-14 20:12:19",
    "許可證字號": "衛部藥輸字第028431號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "117\/02\/02",
    "發證\/登錄日期": "112\/02\/02",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202843100",
    "中文品名": "帝寧膜衣錠150毫克",
    "英文品名": "Erlotinib Sandoz Film Coated Tablets 150mg",
    "適應症": "適用於具有EGFR-TK突變之局部侵犯性或轉移性之非小細胞肺癌（NSCLC）病人之第一線及維持治療。適用於先前已接受過化學治療後，但仍局部惡化或轉移之肺腺癌病人之第二線用藥。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠ALU-OPA\/ALU\/PVC 鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "監視期滿學名藥;",
    "監視期限": "",
    "主成分略述": "ERLOTINIB HYDROCHLORIDE",
    "限制項目": "02輸　入 1Q不得輸入 24監視期滿學名藥",
    "申請商名稱": "台灣山德士藥業股份有限公司",
    "申請商地址": "臺北市中山區民生東路3段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "REMEDICA LTD.",
            "製造廠廠址": "AHARNON STREET, LIMASSOL INDUSTRIAL ESTATE , LIMASSOL 3056, CYPRUS",
            "製造廠公司地址": "",
            "製造廠國別": "CYPRUS",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013001000",
            "成分名稱": "ERLOTINIB HYDROCHLORIDE",
            "含量描述": "(eq. to Erlotinib.....150mg)",
            "含量": "163.9000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "LF_Erlotinib FCT_TWI-270921_仿單格式化20230320-clean-112-04-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52028431&Seq=001&Type=9"
        }
    ]
}